OpenAlex
PricingAboutJobs
Log inGet started
Work

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Diabetes & Endocrinology
DOI: 10.1016/s2213-8587(15)00261-2
Authors: Dick de Zeeuw, Pirow Bekker, Elena Henkel, Christopher Hasslacher, Ioanna Gouni-Berthold, Heidrun Mehling, Antonia Potarca, Vladimir Tesar, Hiddo J Lambers Heerspink, Thomas J Schall
Institutions: University Medical Center Groningen, University of Groningen, ChemoCentryx (United States), Technische Universität Dresden, Diabetesinstitut Heidelberg, University of Cologne, Stiftung Charité, Charité – Universitätsmedizin Berlin, Charles University
Language: English

Topic: Chronic Kidney Disease and Diabetes
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Bayer HealthCare
OpenAlex ID: W2106079757
FWCI: 22.56
Cites: 19
Cited by: 287
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms